SEARCH

SEARCH BY CITATION

References

  • 1
    Tawara S, Nakazato M, Kangawa K, Matsuo H, Araki S. Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type). Biochem Biophys Res Commun 1983; 116:880888.
  • 2
    Saraiva MJ, Costa PP, Birken S, Goodman DS. Presence of an abnormal transthyretin (prealbumin) in Portuguese patients with familial amyloidotic polyneuropathy. Trans Assoc Am Physicians 1983; 96:261270.
  • 3
    Suhr O, Danielsson A, Holmgren G, Steen L. Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy. J Intern Med 1994; 235:479485.
  • 4
    Suhr OB, Ando Y, Holmgren G, Wikstrom L, Friman S, Herlenius G, et al. Liver transplantation in familial amyloidotic polyneuropathy (FAP). A comparative study of transplanted and non-transplanted patient's survival. Transpl Int 1998; 11(suppl 1):S160S163.
  • 5
    Andersson R. Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden. Acta Med Scand 1976; 590(suppl):S1S64.
  • 6
    Steen L, Ek B. Familial amyloidosis with polyneuropathy. A long-term follow-up of 21 patients with special reference to gastrointestinal symptoms. Acta Med Scand 1983; 214:387397.
  • 7
    Tashima K, Suhr OB, Ando Y, Holmgren G, Yamashita T, Obayashi K, et al. Gastrointestinal dysfunction in familial amyloidotic polyneuropathy (ATTR Val30Met)—Comparison of Swedish and Japanese patients. Amyloid 1999; 6:124129.
  • 8
    Adams D, Samuel D, Goulon-Goeau C, Nakazato M, Costa PM, Feray C, et al. The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain 2000; 123:14951504.
  • 9
    Bergethon PR, Sabin TD, Lewis D, Simms RW, Cohen AS, Skinner M. Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation. Neurology 1996; 47:944951.
  • 10
    Holmgren G, Ericzon BG, Groth CG, Steen L, Suhr O, Andersen O, et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 1993; 341:11131116.
  • 11
    Suhr OB, Holmgren G, Steen L, Wikstrom L, Norden G, Friman S, et al. Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients. Transplantation 1995; 60:933938.
  • 12
    Parrilla P, Ramirez P, Andreu LF, Bueno SF, Robles R, Miras M, et al. Long-term results of liver transplantation in familial amyloidotic polyneuropathy type I. Transplantation 1997; 64:646649.
  • 13
    Lång K, Wikström L, Danielsson Å, Tashima K, Suhr OB. Outcome of gastrointestinal complications after liver transplantation for familial amyloidotic polyneuropathy. Scand J Gastroenterol 2000; 35:985989.
  • 14
    Jonsen E, Suhr OB, Tashima K, Athlin E. Early liver transplantation is essential for familial amyloidotic polyneuropathy patients' quality of life. Amyloid 2001; 8:5257.
  • 15
    Suhr O, Holmgren G. Difficulties in clinical diagnosis and prediction of outcome in patients with the transthyretin Met 30 mutation. Report of two cases. Amyloid 1995; 2:179182.
  • 16
    Holmgren G, Holmberg E, Lindstrom A, Lindstrom E, Nordenson I, Sandgren O, et al. Diagnosis of familial amyloidotic polyneuropathy in Sweden by RFLP analysis. Clin Genet 1988; 33:176180.
  • 17
    Familial Amyloidotic Polyneuropathy World Transplant Register (FAPWTR). Available at: www.fapwtr.org. Accessed January 15, 2002.
  • 18
    Suhr OB, Wiklund U, Eleborg L, Ando Y, Backman C, Birgersdotter V, et al. Impact of autonomic neuropathy on circulatory instability during liver transplantation for familial amyloidotic polyneuropathy. Transplantation 1997; 63:675679.
  • 19
    Pomfret EA, Lewis WD, Jenkins RL, Bergethon P, Dubrey SW, Reisinger J, et al. Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy. Transplantation 1998; 65:918925.
  • 20
    Ando Y, Yonehara T, Tanaka Y, Tashima K, Uchino M, Ando M. Early pacemaker implantation in patients with familial amyloidotic polyneuropathy. Muscle Nerve 1996; 19:16401641.
  • 21
    Suhr OB, Wiklund U, Ando Y, Ando E, Olofsson BO. Impact of liver transplantation on autonomic neuropathy in familial amyloidotic polyneuropathy: An evaluation by spectral analysis of heart rate variability. J Intern Med 1997; 242:225229.
  • 22
    Stangou AJ, Hawkins PN, Heaton ND, Rela M, Monaghan M, Nihoyannopoulos P, et al. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: Implications for amyloid fibrillogenesis. Transplantation 1998; 66:229233.
  • 23
    Olofsson B-O, Backman C, Karp K, Suhr OB. Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type. Transplantation 2002; 73:745751.
  • 24
    Suhr OB, Herlenius G, Friman S, Ericzon BG. Liver transplantation for hereditary transthyretin amyloidosis. Liver Transpl 2000; 6:263276.
  • 25
    Jonsén E, Suhr O, Athlin E, Wikström L. Quality of life after liver transplantation in patients with familial amyloidotic polyneuropathy. Amyloid 1996; 3:124129.
  • 26
    Sales Luis ML. Clinical/EMG evaluation of therapeutics in FAP including liver transplantation [abstract]. Eur J Neurol 1999; 6(suppl 3):S180A.